SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of DUSA Pharmaceuticals Inc. (DUSA), Schiff Nutrition International, Inc. (SHF) and The Warnaco Group, Inc. (WRC) and Class Action Against Questcor Pharmaceuticals, Inc. (QCOR)
NEW YORK, Nov. 8, 2012 /PRNewswire/ --
DUSA Pharmaceuticals Inc.
Levi & Korsinsky is investigating the Board of Directors of DUSA Pharmaceuticals Inc. (Nasdaq: DUSA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Sun Pharmaceutical Industries Limited (Reuters: SUN.BO) for $8 per share.
Click here to learn more about the investigation: http://zlk.9nl.com/dusa-pharmaceuticals-dusa, or call: 877-363-5972.
(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )
Schiff Nutrition International, Inc.
Levi & Korsinsky is investigating the Board of Directors of Schiff Nutrition International, Inc. (NYSE: SHF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Bayer HealthCare, LLC for $34 per share.
Click here to learn more about the investigation: http://zlk.9nl.com/shiff-nutrition-international-shf, or call: 877-363-5972.
The Warnaco Group, Inc.
Levi & Korsinsky is investigating the Board of Directors of The Warnaco Group, Inc. (NYSE: WRC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to PVH Corp. under which shareholders will receive $51.75 in cash and 0.1822 of a PVH common share per share.
Click here to learn more about the investigation http://zlk.9nl.com/warnaco-group-wrc, or call: 877-363-5972.
Questcor Pharmaceuticals, Inc.
Levi & Korsinsky announces that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who acquired Questcor Pharmaceuticals, Inc. (NasdaqGS: QCOR) securities between April 26, 2011 and September 21, 2012.
For more information, click here: http://zlk.9nl.com/questcor-pharmaceuticals-qcor. You have until November 26, 2012 to request that the Court appoint you as lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com
SOURCE Levi & Korsinsky, LLP
RELATED LINKS
http://www.zlk.com
More by this Source
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Websense, Inc. in Connection with the Sale of the Company to Vista Equity Partners
May 22, 2013, 10:41 ET
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Asta Funding, Inc.
May 20, 2013, 16:15 ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Theragenics Corporation in Connection with a Going Private Proposal
May 21, 2013, 10:33 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.